A practical TB consumables supplier qualification process
Reliable consumables are central to accurate tuberculosis testing. A laboratory may have skilled staff, validated instruments and strong procedures, yet still face unreliable results if sputum containers leak, molecular cartridges fail, or culture media arrive damaged. Supplier qualification makes purchasing decisions part of the laboratory quality management system rather than an informal exercise based on price or habit.
For Australian TB services, the process needs to work across public hospitals, reference laboratories, private providers and regional facilities. A supplier in Sydney or Melbourne may appear close on paper, while delivery to Darwin, regional Queensland or a Western Australian mining corridor can involve long transport legs, extreme heat and limited replacement options.
The GLI Quality Tool offers a useful structure because its four-phase roadmap connects procurement with the Quality Systems Essentials. Equipment, documents, assessment, safety, personnel and continual improvement all influence whether a consumable is fit for purpose. The aim is a proportionate, documented process that protects testing quality without creating unnecessary administration.
A qualification programme should cover routine items and high-risk products. These may include sample collection containers, swabs, transport media, culture supplies, antimicrobial susceptibility testing materials, molecular assay cartridges, pipette tips, extraction reagents and personal protective equipment. The level of scrutiny should reflect the effect of failure on patient care and surveillance.
| Qualification area | Evidence to request | Practical decision |
|---|---|---|
| Product suitability | Specifications, instructions for use, intended use and compatibility details | Accept, conditionally accept or reject |
| Regulatory status | Australian and overseas regulatory information where relevant | Confirm legal and clinical suitability |
| Manufacturing quality | ISO certificates, batch controls and change notification arrangements | Approve the manufacturer and site |
| Supply reliability | Lead times, stock records, transport conditions and business continuity plans | Set ordering and contingency rules |
| Performance | Verification results, complaints history and nonconformity data | Monitor with defined review dates |
Define the risk before choosing a supplier
Start with an inventory of consumables used in TB testing and divide them into risk groups. A product that directly affects detection, identification or drug susceptibility results deserves stronger controls than a general cleaning item. Consider the impact of a failure, how quickly an alternative can be found, storage requirements, expiry period and the possibility of contamination.
Record the risk assessment in a purchasing or quality form. For example, a leaking specimen container could create a biosafety incident and compromise the sample, while a delayed delivery of cartridges could interrupt a public health response. A simple high, medium and low classification is usually enough, provided the reasons are clear and consistently applied.
The GLI checklists can help laboratories link supplier controls to document management, equipment, assessment and continual improvement activities. Adapt the checklist to the local scope rather than treating it as a form to complete once and file away.
Set clear qualification criteria
Define minimum requirements before contacting vendors. These commonly include product specifications, lot traceability, expiry dates, packaging integrity, storage temperatures, instructions for use, safety information and evidence of compatibility with the laboratory’s methods. Include delivery expectations, customer support and arrangements for recalls or product changes.
For products used with regulated in vitro diagnostic methods, check whether the manufacturer and product have the required Australian status, including relevant Therapeutic Goods Administration requirements and Australian Register of Therapeutic Goods details where applicable. NATA-accredited laboratories should ensure purchasing controls support the requirements of their accreditation and the relevant medical laboratory standards.
Criteria should also cover the supplier’s quality system. ISO 13485 certification may be relevant for medical device manufacturers, but a certificate alone does not demonstrate that a particular product will perform properly in the laboratory. Ask for the certificate scope, manufacturing location, authorised distribution arrangements and evidence that complaints and deviations are investigated.
Gather evidence and check authenticity
Request a consistent evidence pack from each prospective supplier. It may include a completed vendor questionnaire, current product data sheet, safety data sheet, certificate of analysis, regulatory declarations, lot release information, storage and transport conditions, warranty terms and a quality contact. Record document versions and expiry dates so that outdated evidence is not relied upon.
Verify documents through the issuing body, manufacturer website or authorised representative. This is particularly important when a distributor supplies imported products. A reseller may be legitimate while still lacking authority to provide technical support, manage recalls or guarantee cold-chain conditions.
The downloadable GLI materials provide practical resources that can be adapted for questionnaires, records and quality activities. Keep the final approved evidence in a controlled location, with access for procurement, laboratory staff, quality personnel and the person responsible for releasing new products.
Assess samples and supplier capability
Document review should be followed by a practical assessment. Obtain representative samples where possible and check packaging, labelling, lot numbers, expiry, dimensions, compatibility and ease of use. For critical reagents or cartridges, perform verification according to the laboratory’s procedure before routine implementation. Define acceptance criteria in advance, including allowable invalid rates, agreement with the existing method and any effect on turnaround time.
A supplier may be assessed through a remote meeting, technical questionnaire or site audit. An on-site audit is more appropriate when the product is critical, the supply chain is complex, previous performance has been poor or the manufacturer cannot provide adequate evidence. Ask how the supplier controls nonconforming product, manages environmental conditions, trains staff and communicates formulation or packaging changes.
In Australia, a distributor based in Brisbane may provide excellent support to a metropolitan laboratory but have limited reach into northern Queensland. Confirm delivery routes, cut-off times and escalation contacts for regional and remote sites. A fair-dinkum qualification decision considers what happens after the purchase order, not just how polished the sales presentation looks.
Control ordering, receipt and storage
Approval should lead to a controlled purchasing arrangement. Maintain an approved supplier and product list with the supplier name, product code, approved specification, storage conditions, review date and any restrictions. Purchase only through authorised channels, and require prior quality approval for substitutions or changes in manufacturer, formulation, packaging or lot configuration.
At receipt, staff should inspect delivery temperature where relevant, packaging, seals, labels, quantity, lot number, expiry and evidence of damage. Quarantine goods that fail inspection until an authorised person decides whether they can be accepted, returned or discarded. Apply first-expiry-first-out stock rotation and set minimum and maximum stock levels based on consumption, lead time and emergency demand.
Transport planning needs local realism. A shipment travelling from the eastern states to Perth may spend several days in transit, while a delivery to Darwin may encounter high temperatures during the build-up to the wet season. Define acceptable temperature excursions, data logger requirements and escalation steps. Keep enough buffer stock to protect testing continuity without allowing products to expire on the shelf.
Monitor performance after approval
Vendor qualification is incomplete until performance is reviewed. Track delivery timeliness, shortages, damaged goods, temperature excursions, unexpected substitutions, documentation gaps, invalid results, complaints and responsiveness. Use a simple scorecard with agreed thresholds, but allow laboratory staff to report serious events immediately rather than waiting for a scheduled review.
Review critical suppliers at least annually, or more often when risk or performance warrants it. Requalify after a major product change, manufacturing-site change, merger, recall, regulatory concern or repeated failure. A supplier that misses one delivery may need corrective action; a supplier linked to repeated invalid results may need suspension while the cause is investigated.
Include supplier data in management review and internal audits. Examine whether the laboratory’s own ordering, storage or receiving practices contributed to the problem. This avoids blaming a vendor for issues caused by poor forecasting or an unrecorded temperature excursion and supports fair, evidence-based decisions.
Connect procurement with continual improvement
Assign responsibility for each stage of the process. Procurement can manage commercial details, laboratory users can assess technical performance, the quality manager can control records and the laboratory director can approve high-risk suppliers. A clear responsibility matrix prevents assumptions such as “purchasing has checked it” when no one has reviewed product suitability.
Maintain a documented route for complaints, corrective actions and recalls. Staff need to know how to identify affected lots, stop use, notify relevant managers, preserve evidence and assess whether patient or surveillance results require review. For TB laboratories, this may include coordination with infection control, public health units and clinical teams when a failure could affect diagnosis or treatment decisions.
Use trend data to improve the supplier programme. If low-level consumables repeatedly arrive close to expiry, revise ordering frequency or contract terms. If regional deliveries are unstable, qualify a second supplier or establish a local emergency stock. The GLI download centre can support broader quality planning as the laboratory moves from basic controls towards a mature, risk-based system.
A well-run qualification process should be practical enough for a small regional laboratory and robust enough for a high-volume reference service. Begin with the consumables that pose the greatest clinical, biosafety or continuity risk, create consistent evidence requirements, verify performance in use and review suppliers using real data. Make the approved supplier register, receiving checks and corrective-action records part of everyday work, then use the results to strengthen the laboratory’s quality management system.